With the increasing number of gene therapies hitting the market, this segment of the biotech industry must be approaching an inflection point and a related spurt in value growth…read our latest short article to find out more.
Dr. Fergus McWhinnie, TargoPep’s CSO, looks at the story of oligotherapeutic approaches, the current success stories and the direction of research in the field that will provide future cures to today’s ‘uncurable’ diseases.
Dr. Fergus McWhinnie writes about how and why Advanced Delivery Peptides have the potential to transform the delivery of life changing gene therapies to their site of action.
